News & Videos - OLINK HOLDING AB (PUBL) ADS - Page 2

UPPSALA, Sweden, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the second quarter ended June 30, 2023. Highlights Second quarter 2023 revenue totaled $29.4 million, representing year over year growth of 7.0% on a reported basis and 7.2% on a constant currency adjusted like-for-like basis Total Explore customer installations reached 74, with 11 installations during the second quarter Total Signature Q100...

UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has selected the Olink Explore platform as a proteomics component of their world-class multiomics offering. Understanding the complex biological mechanisms of human diseases is essential to identifying effective new therapeutic strategies. The addition of Olink proteomic technology enables a more...

UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market open on Wednesday, August 9, 2023. Company management will host a conference call to discuss these results at 8:00 am ET. Investors interested in listening to the conference call are required to register online . It is recommended to register at least a day in advance. A live webcast of the...

UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink ® Explore HT, a transformational solution for high-throughput proteomics delivering unmatched specificity, scalability, and workflow simplicity. Olink Explore HT represents a significant advancement in next generation proteomics, allowing scientists to accurately measure over 5,300 proteins using only 2µl of sample with a completely reimagined and streamlined...

UPPSALA, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on measurements of approximately 1,500 proteins in over 50,000 participants from the UK Biobank (UKB). The findings will be shared through the Normal Ranges tool on Olink Insight, providing researchers with an unprecedented view into the biological variations in protein levels, measured for the first time at...

UPPSALA, Sweden, May 25, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events: William Blair 43 rd Annual Growth Stock Conference Tuesday, June 6 th Goldman Sachs 44 th Annual Global Healthcare Conference Wednesday, June 14 th at 2:00 pm PT / 5:00 pm ET A live and archived webcast of the Goldman Sachs Global Healthcare Conference will be available on the “Events” section of the...

UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023. Highlights First quarter 2023 revenue totaled $27.5 million, representing year over year growth of 21% on a reported basis and 25% on a constant currency adjusted like-for-like basis Total Explore customer installations reached 63, with 11 installations during the first quarter Total Signature Q100...

UPPSALA, Sweden, April 17, 2023 (GLOBE NEWSWIRE) -- At the A nnual G eneral M eeting (the “AGM”) of Olink Holding AB (publ), reg. no 55 9189 - 7755 , (the “Company”), on 1 7 April 202 3 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www. olink .com . Adoption...

UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market open on Thursday, May 11, 2023. Company management will host a conference call to discuss these results at 8:00 am ET. Investors interested in listening to the conference call are required to register online . It is recommended to register at least a day in advance. A live webcast of the...

UPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink technology and has become the first service provider using the Olink ® Target and Olink ® Flex platforms for targeted protein biomarker discovery on the African continent. D-CYPHR is a new facility co-founded by the Centre for Proteomic and Genomic Research (CPGR) and the Institute of Infectious...

UPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2022 is now available on the Company’s website at https://investors.olink.com/ . About Olink Olink Holding AB (publ) (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products...

UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief Commercial Officer (CCO), effective immediately. Mr. Rossi will lead the Company’s global commercial organization including Sales, Marketing and Sales Operations. He will report to Carl Raimond, President of Olink. “I am delighted to welcome Bruno to the Olink organization, and look forward...

UPPSALA, Sweden, March 15, 2023 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”) , reg. no . 559189-7755 , are hereby given notice to attend the Annual Gener al Meeting to be held at 4:00 p.m. CET on Monday the 1 7 A pril 202 3 , in the Company’s facilities at Salagatan 18B, Uppsala . Registration for the meeting commences at 3:30 p.m. CET. NOTICE OF PARTICIPATION Shareholders who wish to attend in the proceedings of the Annual General Meeting...

UPPSALA, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has launched the NUS Medicine Protein Biomarker Discovery Core Facility, which will provide the Olink ® Explore 3072, Olink ® Explore 1536, Olink ® Target 96 and Target 48, and the recently launched Olink ® Flex platforms. These solutions for advanced protein biomarker research range from high-plex,...

UPPSALA, Sweden, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2022. Highlights Fourth quarter revenue totaled $57.9 million, representing year over year growth of 33% on a reported basis and 37% on a constant currency adjusted like-for-like basis Full year 2022 revenue totaled $139.8 million, achieving year over year growth of 47% on a reported basis...

Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of a public offering of 5,831,028 American Depositary Shares, each representing one common share of the Company (the “ADSs”), consisting of 4,250,000 ADSs offered by the Company and 1,581,028 ADSs offered by certain selling shareholders of the Company (the “Selling Shareholders”), at a price to the public of $20.00 per ADS. In addition,...

Uppsala, Sweden, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) (“ Olink ” or the “ Company ”), today announced the launch of a public offering of 5,831,028 American Depositary Shares, each representing one common share of the Company (the “ ADSs ”), consisting of 4,250,000 ADSs offered by the Company and 1,581,028 ADSs offered by certain selling shareholders of the Company (the “ Selling Shareholders ”). In addition, the Company is expected to grant the...

UPPSALA, Sweden, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced its participation in the 41 st Annual JP Morgan Healthcare Conference. Company management will present on Wednesday, January 11 th , 2023 at 7:30 am PT. A live and archived webcast of the event will be available on the “Events” section of the Company’s website at https://investors.olink.com/news-events/events . About Olink Olink Holding AB (publ) (Nasdaq: OLK) is a...

UPPSALA, Sweden, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain at the Biomarkers of the Future conference in Paris, France. Novelties in Biomarkers is an annual award established in 2019 by Olink Proteomics with the purpose of encouraging and motivating young scientists in the use of biomarker discovery in their...

UPPSALA, Sweden, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink ® Flex , a fully flexible made-to-order product to select and combine up to 21 human proteins using absolute quantification in one biomarker panel. With the introduction of Olink ® Flex, the Company offers a mix-and-match solution for efficient creation of custom protein biomarker panels with uncompromised data quality, unparalleled specificity, high...